Cargando…

Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema

PURPOSE: To investigate whether baseline optical coherence tomography (OCT) parameters can predict the treatment frequency of intravitreal ranibizumab (IVR) injections during the first year in patients with diabetic macular edema (DME) treated with pro re nata (PRN) IVR injections. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Yuki, Murakami, Tomoaki, Suzuma, Kiyoshi, Ishihara, Kenji, Yoshitake, Shin, Fujimoto, Masahiro, Dodo, Yoko, Yoshitake, Tatsuya, Miwa, Yuko, Tsujikawa, Akitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391111/ https://www.ncbi.nlm.nih.gov/pubmed/28407012 http://dx.doi.org/10.1371/journal.pone.0175809

Ejemplares similares

Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
por: Yoshitake, Tatsuya, et al.
Publicado: (2019)

Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema
por: Yoshitake, Tatsuya, et al.
Publicado: (2020)

Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema
por: Mori, Yuki, et al.
Publicado: (2016)

Anti-Hexokinase 1 Antibody as a Novel Serum Biomarker of a Subgroup of Diabetic Macular Edema
por: Yoshitake, Tatsuya, et al.
Publicado: (2019)

Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography
por: Dodo, Yoko, et al.
Publicado: (2017)

Decorrelation Signal of Diabetic Hyperreflective Foci on Optical Coherence Tomography Angiography
por: Murakami, Tomoaki, et al.
Publicado: (2018)

Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment
por: Terada, Noriko, et al.
Publicado: (2020)

Clinical Relevance of Parafoveal Intercapillary Spaces and Foveal Avascular Zone in Diabetic Retinopathy Without Macular Edema
por: Terada, Noriko, et al.
Publicado: (2022)

Relationship between Functional and Structural Changes in Diabetic Vessels in Optical Coherence Tomography Angiography
por: Miwa, Yuko, et al.
Publicado: (2016)

Association between retinal hemorrhagic pattern and macular perfusion status in eyes with acute branch retinal vein occlusion
por: Muraoka, Yuki, et al.
Publicado: (2016)

Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema
por: Murakami, Tomoaki, et al.
Publicado: (2023)

In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography
por: Murakami, Tomoaki, et al.
Publicado: (2016)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
por: Ogino, Ken, et al.
Publicado: (2011)

Comparisons of Efficacy of Intravitreal Aflibercept and Ranibizumab in Eyes with Diabetic Macular Edema
por: Shimizu, Norihiro, et al.
Publicado: (2017)

Branch Retinal Vein Occlusion: Treatment Outcomes According to the Retinal Nonperfusion Area, Clinical Subtype, and Crossing Pattern
por: Iida-Miwa, Yuko, et al.
Publicado: (2019)

Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim, Moosang, et al.
Publicado: (2013)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart, Michael W
Publicado: (2013)

Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
por: Fong, Angie HC, et al.
Publicado: (2013)

The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment
por: Nowacka, Barbara, et al.
Publicado: (2016)

Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
por: Lim, Laurence S, et al.
Publicado: (2015)

Renal Biomarkers for Treatment Effect of Ranibizumab for Diabetic Macular Edema
por: Lai, Ivan Pochou, et al.
Publicado: (2020)

Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
por: Ohara, Hiromi, et al.
Publicado: (2023)

The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients
por: Murata, Toshinori, et al.
Publicado: (2021)

Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy
por: Kawai, Kentaro, et al.
Publicado: (2022)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
por: Demircan, Ali, et al.
Publicado: (2018)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020)

Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
por: Bandello, Francesco, et al.
Publicado: (2011)

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2012)

Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment
por: Kaya, Mahmut, et al.
Publicado: (2018)

Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2017)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
por: Gabr, Ahmed F., et al.
Publicado: (2023)

Author Correction: The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment‑naïve patients
por: Murata, Toshinori, et al.
Publicado: (2021)

Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration
por: Shiragami, Chieko, et al.
Publicado: (2017)

Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusion
por: Nagasato, Daisuke, et al.
Publicado: (2020)

Intravitreal Ranibizumab Versus Intravitreal Ranibizumab Combined with Posterior Subtenon Triamcinolone Acetonide in Diabetic Macular Edema
por: Karatas, Gamze, et al.
Publicado: (2021)

MACULAR BLOOD FLOW CHANGES IN BRANCH RETINAL VEIN OCCLUSION EXAMINED BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VARIABLE INTERSCAN TIME ANALYSIS
por: Nishigori, Naomi, et al.
Publicado: (2022)

Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
por: Keane, Pearse A, et al.
Publicado: (2011)

Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
por: Azad, Rajvardhan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6kbatpfjqthf6q9ubo0qv2v86k